Financial figures/persons Page 48

Newsflash

• Mrs. Trump Makes A Rare Statement: I Have Never Met Epstein And Calls For Congress To Hold A Hearing

  

  U.S. First Lady Melania Trump made a rare televised speech from the White House Grand Foyer on Thursday, strongly denying any substantive relationship with the late sex offender Jeffrey Epstein and calling on Congress to hold public hearings for Epstein's victims. This "explosive" statement not only caught the political circles in Washington off guard, but what is even more shocking is that according to multiple media reports, even President Donald Trump himself had "no prior knowledge" or only learned about it at the last minute.

  Melania said categorically in her statement: "The lies linking me to the shameful Jeffrey Epstein must end today." She made it clear that she had never developed a friendship with Epstein or his accomplice Ghislaine Maxwell, and only occasionally attended parties together because of the overlapping social circles in New York and Palm Beach. She denied taking Epstein's plane or visiting his private island, and emphasized: "I am not a victim of Epstein. Epstein did not introduce me to Donald Trump." She also mentioned the details of her first encounter with Trump in 1998 recorded in her book to refute relevant speculation.

  The most impactful part of the statement is Melania’s initiative to push the issue to a broader level. She pointed out that "Epstein was not alone" and urged Congress to "take immediate action" to provide the victims with the opportunity to testify under oath and let their stories be permanently recorded in the congressional record: "Every woman should have the opportunity to tell her story publicly, if she chooses." This call quickly received a response from some Democratic lawmakers (such as Rep. Ayanna Pressley), but it also caused uneasiness within the Republican Party, believing that it could reignite an old scandal that the Trump administration hopes to downplay.

  What is even more striking is the “uncoordinated” nature of this speech. According to people familiar with the matter and multiple media reports, Melania’s decision was not fully coordinated in advance according to regular White House procedures. When asked briefly after the statement, President Trump said he had "no prior knowledge" of his wife's move or only learned about it "very late." Trump also defended his wife, saying "she didn't know (Epstein)." This detail was described by many media as "shocking Washington", highlighting the independence and suddenness of Melania's action.

  Recently, the Epstein files have been further exposed, including emails mentioning Melania and other materials. The Daily Telegraph and other media highlighted relevant reports on their front pages, while Melania’s net favorability has dropped to a historical low at the same stage of the modern First Lady’s second term. This speech was seen as her attempt to proactively cut through negative narratives, but objectively brought the Epstein case back to the center of public attention.

  Mainstream media reacted strongly. CNN, NBC, NPR, Reuters, "Washington Post" and "New York Times" all reported prominently, describing the move as "extraordinary" and "rare." Analysts pointed out that Melania has always been known for being low-key and mysterious. This time she took the initiative to stand in front of the camera, which may be aimed at ending the long-standing speculation, but unexpectedly brought the political focus back to the area that her husband least wanted to face. It is currently unclear whether Congress will respond to its call for hearings, but the incident has ensured that the scandal will continue to ferment in 2026.

  55 minutes ago

• The Situation Between Russia And Ukraine On April 9: The Latest Updates On Body Exchange, Ceasefire Decision, Meeting Location, Etc.

  According to CCTV News, a reporter from the main station learned on April 9, local time, that according to First Vice Chairman of the Russian State Duma International Affairs Committee Shamsail Salaliyev, Russia and Ukraine conducted a new round of exchange of remains of fallen soldiers that day. Russia handed over 1,000 bodies to Ukraine, and Ukraine handed over 41 bodies to Russia.

  

  Russia says Putin has not yet made a decision on Ukraine’s ceasefire initiative

  Previously, Russian Presidential Press Secretary Peskov pointed out in a regular briefing on April 9 that Russian President Putin has not yet made any decision on the ceasefire this Sunday (Easter).

  In response to the news that Russian frigates escorted oil tankers through the English Channel, Peskov said that due to repeated piracy in international waters, Russia has the right and will take measures to protect its own interests. The British side has previously stated that it will intercept the so-called "shadow fleet".

  Peskov reiterated that Russia seeks to establish mutually beneficial relations with all countries, including European countries that are unwilling to engage with Russia. Regarding France's remarks that Russia is a threat, he called it "completely baseless." He also revealed that the Kremlin is preparing for contacts between Putin and Indonesian leaders, and relevant information will be communicated in due course.

  

  Zelensky: Willing to meet Putin, but not in Moscow

  According to CCTV News, a reporter from the main station learned on April 9, local time, that Ukrainian President Zelensky expressed his willingness to meet with Putin, but not in Moscow. He said the meeting could take place in the Middle East, Europe, the United States or other suitable locations.

  Regarding the election, Zelensky said that holding the election now violates Ukrainian law. In addition, election voting needs to ensure security, and security conditions are not currently met.

  Zelensky had previously changed his tune and said he was willing to hold trilateral talks between Ukraine, the United States and Russia anywhere.

  Our reporter learned that on March 27, local time, Ukrainian President Zelensky stated in an interview that due to security restrictions, the US negotiating team could only meet in the United States, while the Russian side was unwilling to go to the United States for negotiations.

  

  Zelensky said that Ukraine "communicates with the United States every day" but "encounters difficulties" and feels that it is a mediator in the negotiation process rather than a party to the conflict. He said that due to the situation in the Middle East and security concerns, the United States can only hold negotiations in the United States, while Russia is "willing to hold talks anywhere except the United States." Zelensky said that Ukraine is willing to host a trilateral meeting at any location.

  Zelensky stressed that Ukraine is making every effort to promote the implementation of the trilateral meeting, and pointed out that the meeting can be held in Europe, Türkiye, Switzerland or the Middle East.

  2 hours ago

• Frequently Asked Questions In Laboratory Interviews And Key Points Of Internship Experience

  Time flies like an arrow, and the sun and moon fly like a shuttle. My one-year internship here has passed quickly. Looking back on the past year, I can't help but feel full of emotions. I was officially accepted by the hospital as an intern in the laboratory department in July. During this year's internship, I have continuously strengthened my study, improved my political quality and business quality, accurately positioned myself, and worked hard to do my job well. The internship situation over the past year is now reported as follows: In just a few months, under the correct leadership of the party and government leaders of the hospital, under the leadership of the director of the laboratory department,

  Under the leadership, I earnestly study various professional knowledge, forge ahead, seek truth and be pragmatic, carry forward the work style of advancing with the times, adhere to the "patient-centered" clinical service concept, base on my position, and do a good job in medical services. The summary mainly includes the following items:

  one. Be conscientious and do your job well

  As a member of the laboratory department, I am both the doctor's eyes and the doctor's assistant. Grasping my own responsibilities is another principle I have followed since I took office. Apply the knowledge you have learned, collect the opinions of teachers, learn from experience in other places, put forward opinions and suggestions, and serve as a good consultant to doctors. So far, it has basically been able to meet the testing parameter requirements of various types of patients in the hospital; in order to ensure the accuracy of testing data for various types of patients, the entire process of inspection and testing was strictly carried out in accordance with the "National Clinical Inspection Operating Procedures" and "Product Instructions". In the past year, the inspection reports issued were basically accurate. In the inspection business, we can resolutely implement the concept of medical safety first and prevent the occurrence of medical accidents. Further improve the quality of medical services and improve service attitude to win the trust of patients.

  2. Professional knowledge, work ability and specific work

  Although the daily clinical testing work is relatively busy, there are certain difficulties in doing it. For example, I have never done a lot of manual sample addition work before. However, in order to do a good job, obey the leadership arrangements, and actively support the work of the department director, I am not afraid of trouble. I humbly learn from the teacher and explore my own practice. In a short period of time, I have mastered the manual sample addition work, clarified the work procedures, improved my work ability, and formed a clearer work idea in the specific work. I can carry out the work smoothly and complete my job skillfully and satisfactorily. In order to make up for the gaps in my professional knowledge, I

  I constantly ask myself to supplement this knowledge every day, which will lay a solid foundation for myself and future interviews.

  3. Work attitude and diligence and dedication

  "A doctor has the heart of a parent", and I take it as my own responsibility to do everything possible to relieve the suffering of patients. I hope that all patients can recover as soon as possible, so every time when I enter the ward, I use the limited time to spare no effort to encourage them, patiently help them understand the disease, build confidence in overcoming the disease, and silently pray for their speedy recovery. Love your own job, be able to treat every job correctly and seriously, and serve everyone enthusiastically. Seriously abide by labor disciplines, ensure timely attendance, make effective use of working time, stick to your post, and work overtime to complete work on time.

  4. I also received criticism and corrections from all aspects at work. I made rectifications one by one and achieved good results.

  In the past few months of my internship, under the leadership of the hospital leaders and department directors, I have worked diligently and diligently. Although I have achieved some results, since my various qualities need to be further improved, it is inevitable that problems and mistakes of this kind and that will occur in my work. For example, individual work is not perfect enough, which needs to be improved in future work. I sincerely hope that all leaders and teachers can provide timely criticism and correction. The new year means a new starting point, new opportunities, and new challenges. I am determined to continue to work hard, reach a higher level, strive to create a new situation in work, bring ideological awareness and work performance to a new level, and make greater and more contributions to the development of the General Hospital.

  4 hours ago

• Can Kingfa Technology’s Share Price Double? New Material Investment Value Analysis

  In-depth analysis of Kingfa Technology: performance elasticity, doubling cycle and valuation positioning

  As a global leader in modified plastics, Kingfa Technology focuses on the field of new chemical materials and creates a coordinated development pattern of "modified plastics + degradable plastics + new materials". Its core business covers 9 categories of products including modified plastics, fully biodegradable plastics, and special engineering plastics, which are widely used in automobiles, home appliances, In many fields such as electronics and electrical engineering, new energy, and medical health, operations are closely related to the recovery of the global new chemical materials industry, policy dividends for degradable plastics, and rising demand for downstream emerging industries. Benefiting from the recovery of the modified plastics industry, the increase in degradable plastics, and new material business breakthroughs, long-term growth is more certain. Based on the company's latest data (stock price 15.85 yuan, total market value 41.76 billion), this article simplifies the calculation of the stock price doubling cycle and determines the rationality of the current pricing. The full text is controlled to a reasonable length to provide a reference for investors. Follow Niu Xiaowu

  1. Institutional performance and target price prediction: How long will it take for the stock price to double? 1. Core performance forecast (2026-2028)

  Combining the latest financial reports and institutional forecasts, Kingfa Technology’s operations continue to recover and its profitability has increased significantly. In 2024, the company will achieve total operating income of 60.514 billion yuan and net profit attributable to the parent company of 825 million yuan; in 2025, revenue will grow steadily. In the first three quarters, it has achieved net profit attributable to the parent company of 1.065 billion yuan, a year-on-year increase of 55.86%. The net profit attributable to the parent company for the year is expected to be 1.504 billion yuan. The core benefit is the recovery of the modified plastics industry, product sales and gross profits, and the expansion of overseas business scale. Net profit attributable to the parent company will maintain rapid growth from 2026 to 2028, with a compound annual growth rate of approximately 28%-33%. It is expected to be 1.976 billion yuan in 2026, 2.489 billion yuan in 2027, and 3.120 billion yuan in 2028. The core benefit is from the policy dividend of degradable plastics, the expansion of new material business and the continued optimization of cost control. The company's share capital is 2.635 billion shares (calculated based on a total market value of 41.76 billion and a stock price of 15.85 yuan). At the end of 2025, total assets were 63.795 billion yuan, total liabilities were 42.310 billion yuan, and total shareholders' equity was The total amount is 21.484 billion yuan, the asset-liability ratio is 66.32%, and operating cash flow is abundant. The net cash flow from operating activities in the first three quarters of 2025 will reach 2.320 billion yuan, providing solid support for business expansion and technology research and development.

  2. Institutional target price and doubling cycle calculation

  The current stock price is 15.85 yuan, and the doubled target price is 31.70 yuan, corresponding to a total market value of 83.52 billion yuan.

  From a comprehensive institutional point of view, the company is optimistic about the company's leading position in modified plastics, core technology advantages and the second curve potential of degradable plastics in the long term. It recognizes its performance recovery elasticity and industry track dividends, and is optimistic about the long-term opportunities brought by the recovery of the new chemical materials industry and the promotion of degradable plastics policies. Many institutions have given "buy" and "overweight" ratings. The institution's comprehensive target price has reached 26.00 yuan, which is a significant premium over the current stock price and is in line with the valuation and performance growth expectations of the new chemical materials sector. Simplified calculation of the doubling cycle (using performance in 2026 as the core calculation benchmark):

  Optimistic scenario: Performance growth is 33%, valuation remains at 21 times PE (2026 baseline), and stock price is expected to double in 2.7-3.0 years. Neutral scenario: Performance growth is 30.5%, valuation remains at 19 times PE (2026 baseline), and stock price is expected to double in 3.0-3.3 years. Conservative scenario: Performance growth is 28%, valuation remains at 17 times PE (2026 baseline), and stock price is expected to double in 3.3-3.6 years.

  Core conclusion: Relying on the leading advantages of modified plastics, policy dividends for degradable plastics and breakthroughs in the new material business, Kingfa Technology’s share price has a neutral expectation of doubling in 3.0-3.3 years and an optimistic expectation of doubling in 2.7-3.0 years. It conforms to the core attributes of the modified plastics + degradable plastics track’s recovery and growth and high prosperity, reflecting the market’s recognition of its long-term value and performance recovery potential.

  2. Mainstream valuation methods: Is the current stock price undervalued or a bubble? 1. Price-to-earnings ratio (PE) valuation method (core reference)

  Comparison baseline:

  Judgment: Basically reasonable and consistent with recovery and growth attributes. The dynamic PE is within the reasonable range of the industry, matching the compound performance growth rate of 28%-33%. Combined with the recovery in demand for modified plastics and the increase in the volume of degradable plastics, there is no long-term bubble risk, and it has strong potential for valuation improvement.

  2. Price-to-book ratio (PB) valuation method (core reference) 3. Price-to-sales ratio (PS) valuation method (auxiliary reference) 4. Discounted cash flow (DCF) valuation method 5. Segment valuation (SOTP) method 3. Comprehensive judgment and core logic 1. Valuation positioning

  Combining the five major valuation methods, the current valuation of Kingfa Technology is basically reasonable. There is room for valuation improvement due to the recovery of the new chemical materials industry, the increase in degradable plastics, and the coordinated development of the two tracks. It is basically matched with the compound performance growth rate of 28%-33%. There is no long-term bubble risk. The current stock price has a high match with the intrinsic value, which is in line with the industry logic of the upgrading of the new chemical materials industry and the implementation of the degradable plastics policy. At the same time, the current valuation has not fully reflected the full growth potential of the degradable plastics and new materials business, and there is sufficient room for subsequent catalysis.

  2. Core supporting logic

  The company has outstanding core competitiveness and strong growth certainty: As a global leader in modified plastics, it has a complete range of products and a leading global market share of modified plastics. Its technology in the fields of degradable plastics and special engineering plastics has reached internationally advanced levels; its customers include well-known domestic and foreign automobile companies and home appliance companies. Relying on customized overall solutions and professional technical support, its customers are extremely sticky; benefits With policy dividends for degradable plastics, production capacity continues to be released, and at the same time, it focuses on the fields of new materials such as carbon fiber and PEEK to improve the product matrix; overseas business scale continues to expand, and multiple procurement models are coordinated to ensure the supply of raw materials, with significant cost control advantages; R&D investment continues to increase, technical barriers are deep, and the ability to withstand industry cycle fluctuations is strong, supporting performance recovery and valuation improvement.

  4. Summary

  Kingfa Technology’s current market value of 15.85 yuan and 41.76 billion is within a basically reasonable range, with clear room for valuation improvement and no long-term bubble risk. Based on the consensus forecast of institutions, the stock price is expected to double in 3.0-3.3 years under the neutral scenario and 2.7-3.0 years under the optimistic scenario. As a global leader in new chemical materials, the company has strong technical strength, a comprehensive product matrix and a clear growth direction. It occupies a core position in the recovery of the new chemical materials industry, the promotion of degradable plastics policies and the explosion of demand in downstream emerging industries. Benefiting from industry dividends, leading advantages and second curve empowerment, the company has strong performance growth certainty, outstanding core competitiveness, broad medium and long-term growth space, and high investment value. It is suitable for long-term value investors who are optimistic about new chemical materials, degradable plastics track, and can withstand certain industry cycle fluctuations. Follow Niu Xiaowu to get more in-depth analysis of high-quality stocks.

  5 hours ago

• Laboratory Interview: How To Avoid Doctor-patient Disputes And Answers To Related Interview Questions

  1. How to avoid doctor-patient disputes in the laboratory

  To avoid doctor-patient disputes in the laboratory, you can start from the following aspects:

  First, improve service quality. Examiners should be enthusiastic and patient, communicate with patients in gentle language, and answer questions carefully to reduce patients' anxiety and misunderstandings. For example, when informing patients of test precautions, they should be clear and concise to avoid patients being dissatisfied due to unclear information.

  Second, ensure that the inspection results are accurate. Strictly follow inspection operation procedures and standards, strengthen quality control, and regularly calibrate instruments and equipment to ensure reliable inspection results. At the same time, a complete review system is established to conduct multi-level review of inspection reports to prevent erroneous reports.

  Third, strengthen doctor-patient communication. Before the test, explain the purpose, significance and process of the test items to the patient so that the patient fully understands. After the examination, the results will be reported back to the patient in a timely manner. If the results are abnormal, the situation will be explained in detail and further suggestions will be provided.

  Fourth, standardize management processes. Optimize the inspection process and reduce patient waiting time. Strengthen sample management to ensure that sample collection, transportation and storage meet requirements to avoid result errors caused by sample problems.

  Fifth, strengthen personnel training. Improve the professional skills and comprehensive quality of inspection personnel so that they have the ability to deal with various problems. At the same time, enhance legal awareness, understand medical-related laws and regulations, and practice medicine in accordance with the law.

  2. How to avoid doctor-patient dispute interview questions

  To avoid doctor-patient disputes, you can start from the following aspects:

  First, strengthen doctor-patient communication. Doctors should patiently listen to patients' appeals, understand the condition in detail, and explain disease diagnosis, treatment plans, prognosis, etc. to patients and their families in plain and easy-to-understand language, so that patients can fully participate in the medical decision-making process and enhance their understanding and trust in treatment.

  Second, improve the quality of medical services. Doctors need to continuously improve their professional skills, strictly abide by diagnosis and treatment standards and operating procedures, and avoid disputes caused by misdiagnosis, missed diagnosis, mistreatment, etc. At the same time, hospitals should optimize service processes, improve the medical environment, improve service efficiency, and reduce patient waiting times.

  Third, pay attention to humanistic care. Pay attention to the patient's psychological needs, respect the patient's personality and privacy, give the patient sufficient care and comfort, and make the patient feel warm and respected, which helps to establish a good doctor-patient relationship.

  Fourth, improve medical risk management. Hospitals should establish and improve medical risk assessment, early warning and treatment mechanisms to promptly discover and deal with potential medical risks. Strengthen medical record management, ensure that medical records are written in a standardized, complete and accurate manner, and provide strong evidence for the handling of medical disputes.

  Fifth, strengthen the legal awareness of both doctors and patients. Doctors should understand relevant laws and regulations and practice medicine in accordance with the law; patients should also understand their rights and obligations and resolve disputes through legal channels.

  3. How to avoid doctor-patient disputes

  To avoid doctor-patient disputes, you can start from the following aspects:

  First, improve the quality of medical services. Doctors should continuously improve their professional skills, strictly follow medical operating standards and diagnosis and treatment guidelines for diagnosis and treatment, and reduce disputes caused by technical errors. At the same time, hospitals should strengthen management, improve quality control systems, and conduct regular inspections and evaluations of medical quality.

  Second, strengthen doctor-patient communication. Doctors must patiently listen to patients’ appeals and concerns, and use easy-to-understand language to explain the condition, treatment plans, expected effects, and possible risks to patients and their families, so that they can fully understand the treatment process and enhance trust. Establish a good communication mechanism to answer patients' questions in a timely manner to avoid misunderstandings caused by information asymmetry.

  Third, pay attention to humanistic care. Medical staff must respect the patient's personality and rights, care about the patient's psychological feelings, and provide them with adequate humanistic care. A good service attitude can relieve patients' tension and create a harmonious doctor-patient relationship.

  Fourth, standardize the writing of medical documents. Medical documents are important records of the medical process and should be written accurately, completely and in a timely manner to avoid unnecessary trouble caused by defects in the documents when disputes arise.

  Fifth, establish and improve a complaint handling mechanism. Hospitals should set up specialized complaint handling departments to promptly accept complaints and opinions from patients, handle disputes fairly and objectively, and resolve conflicts in the bud.

  The above are relevant answers on how to avoid doctor-patient disputes in the laboratory. If you are encountering legal problems and don’t know how to solve them? Or you really can’t find a suitable lawyer, please click the consultation button and we can match you with the most suitable local professional lawyer based on your general situation.

  7 hours ago

• Sinoma Technology Investment Analysis: How Long Will It Take To Double The Performance? Look At The Valuation At A Glance

  In-depth analysis of Sinoma Technology: performance elasticity, doubling cycle and valuation positioning

  As of April 3, 2026, the closing price of Sinoma Technology A shares was 39.72 yuan, with a total market value of 66.66 billion yuan. As a leading enterprise in the field of new materials in China, the company focuses on the three core areas of wind power blades, glass fiber and lithium film. It is the global leader in wind power blades and the top three in the domestic glass fiber industry. It has also deployed in the field of new energy materials and formed a "wind power + glass fiber + lithium film" diversified coordinated development pattern. Benefiting from the explosion of global wind power installations, the emergence of supply and demand inflection points in the glass fiber industry, AI and new energy vehicles driving the growth of glass fiber demand and the industry's self-discipline "anti-involution" policy, the current valuation and growth space have attracted market attention. Based on the latest forecasts from domestic and foreign institutions, this article estimates the period required for the stock price to double, and uses mainstream valuation methods to determine whether the current pricing is undervalued or in the bubble range. Follow Niu Xiaowu

  1. Institutional performance and target price prediction: How long will it take for the stock price to double? 1. Core performance forecast (2026-2028)

  In 2025, Sinoma Technology will achieve revenue of 24.86 billion yuan (+58.2%), net profit attributable to the parent company of 2.83 billion yuan (+143%), non-net profit after deducting 2.79 billion yuan (+145.3%), and adjusted net profit of 2.81 billion yuan (+144 .1%), performance achieved explosive growth and hit a record high, mainly benefiting from the increased demand for wind turbine blades, the cyclical recovery of the fiberglass industry and product price increases, and the steady contribution of the lithium film business. At the same time, the company's core business competitiveness continued to improve, and its industry position was further consolidated. In 2025, the company's wind power blade business revenue will account for approximately 48.2%, glass fiber business will account for approximately 42.5%, and lithium film and other businesses will account for approximately 9.3%. Among them, the gross profit margin of the glass fiber business increased by 8.7 percentage points year-on-year to 29.5%, and the gross profit margin of the wind power blade business remained at 28.3%. The profitability of the core business has improved significantly. The company's core advantage lies in its global market share of wind turbine blades, which ranks among the top three in the country. Its glass fiber business ranks among the top three in the country (market share 17%). The cumulative wind turbine blade orders on hand exceed 80GW. Within 90 days, a total of 9 institutions gave ratings, of which 8 were buys and 1 was increase.

  2. Institutional target price and doubling cycle calculation

  The current stock price is 39.72 yuan, and the doubled target price is 79.44 yuan, corresponding to a total market value of 133.32 billion yuan.

  Target price of international institutions:

  Doubling period calculation (three scenarios):

  Optimistic scenario: performance growth rate of 48%+, valuation restored to 28 times PE (the recovery of the fiberglass industry + the high prosperity of wind power, the reasonable valuation range of leading companies, in line with the upward logic of the industry cycle) net profit in 2027 is 5.15 billion yuan, corresponding to a market value of 144.20 billion yuan (≈86.2 yuan), doubling in about 1.8-2.1 years. Neutral scenario: Performance growth rate of 36%, valuation maintained at 24 times. PE's net profit in 2027 is 4.92 billion yuan, corresponding to a market value of 118.08 billion yuan (≈70.6 yuan). Net profit in 2028 is 5.85 billion yuan, corresponding to a market value of 140.40 billion yuan (≈84.0 yuan), doubling in about 2.6-2.9 years. Conservative scenario: performance growth rate of 25%-30%, valuation of 20 times, PE's net profit in 2027 is 4.53 billion yuan, corresponding to a market value of 90.60 billion yuan (≈54.2 yuan), and net profit in 2028 is 5.44 billion yuan yuan, corresponding to a market value of 108.80 billion yuan (≈65.1 yuan), and a net profit of 6.80 billion yuan in 2029, corresponding to a market value of 136.00 billion yuan (≈81.4 yuan), doubling in about 3.8-4.2 years.

  Core conclusion: With the combined force of the elastic release of performance + the inflection point of supply and demand in the fiberglass industry + the explosion of wind power installed capacity, Sinoma Technology's stock price has a neutral expectation of 2.6-2.9 years and an optimistic expectation that it can double in 1.8-2.1 years; if fiberglass prices fall, wind power installed capacity falls short of expectations, or industry competition intensifies, the cycle will be extended to more than 5.0 years.

  2. Mainstream valuation methods: Is the current stock price undervalued or a bubble? 1. Price-to-earnings ratio (PE) valuation method (the core)

  Comparison baseline:

  Judgment: Reasonable valuation, no bubble. The dynamic PE is lower than the industry average and is highly consistent with the 36% performance compound growth rate. As the wind power blades and fiberglass businesses continue to increase in volume and performance elasticity is released in 2026, the PE is expected to fall back to about 13.55 times in 2027. The valuation matches the growth pace and there is no obvious bubble. It is in line with the cyclical recovery of the fiberglass industry and the characteristics of the wind power boom.

  2. Price-to-book ratio (PB) valuation method 3. Price-to-sales ratio (PS) valuation method 4. Discounted cash flow (DCF) valuation method 5. Segment valuation (SOTP) method 3. Comprehensive judgment and core logic 1. Valuation positioning: reasonably low, no bubble 2. Core support logic 3. Risk warning 4. Summary

  Sinoma Technology's current market value of 39.72 yuan and 66.66 billion is in a reasonably low range, and there is no bubble risk. Based on the consensus forecast of institutions, the stock price is expected to double in 2.6-2.9 years under the neutral scenario and 1.8-2.1 years under the optimistic scenario. As a global leader in wind power blades and a leader in domestic fiberglass, the company has benefited from the cyclical recovery of the fiberglass industry, the explosion of wind power installed capacity and the synergy of diversified businesses. It has considerable performance flexibility, has room for slight correction in valuation, and has outstanding medium and long-term investment value. Follow Niu Xiaowu to get more in-depth analysis of high-quality stocks.

  8 hours ago